by DMCBiotech | May 13, 2021 | DMC Press Releases, News
13 May 2021 – DMC Biotechnologies has completed downstream processing for its first product, the amino acid L-alanine. The downstream processing was done at EW Biotech in Leuna, Germany following the successful demonstration of commercial scale fermentation at the...
by DMCBiotech | Apr 7, 2021 | DMC Press Releases, News
7 April 2021 – DMC Biotechnologies has executed an agreement with SCG Chemicals Co., Ltd to bring DMC’s L-Alanine and branched chain amino acids (BCAAs) into the ASEAN* markets. SCG was an investor in DMC’s Series A round in December 2019. Matt Lipscomb, Ph.D., CEO...
by DMCBiotech | Mar 24, 2021 | DMC Press Releases, News
24 March 2021 – DMC Co-Founder Mike Lynch has launched a web-based calculator to assess the economic feasibility of products made from fermentation. The Bioprocess Technoeconomic Analysis (TEA) tool will help users – academics, startups, funding agencies, R&D...
by DMCBiotech | Mar 18, 2021 | DMC Press Releases, News
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the performance at bench and pilot scales,...
by DMCBiotech | Jan 18, 2021 | DMC Press Releases, News
18 January 2021 – Rusty Pittman joins the DMC team as VP Business Development. With over 25 years commercial experience in the chemical, building materials and renewable energy industries, Rusty joins DMC from Elevance Renewable Sciences, Inc where he spent the last...
